Tempest Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Tempest Therapeutics, Inc. (TPST) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.86 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 10.71M shares, a 2276.42% increase year-over-year.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 450.57K shares, a 79.08% decline year-over-year.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 2.15M shares, a 98.92% increase year-over-year.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 1.08M shares, a 74.35% decline year-over-year.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.62M shares, a 406.31% increase from fiscal 2024.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 320.55K shares, a 91.30% decline from fiscal 2023.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.69M shares, a 136.37% increase from fiscal 2022.
- Tempest Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.56M shares, a 95.70% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 33 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 36 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 11.86M shares 10-Q · filed 2026-08-13 | |||||||||
| 2025-12-31 | 1.62M shares 10-K · filed 2026-03-30 | |||||||||
| 2025-09-30 | 450.57K shares 10-Q · filed 2025-11-05 | |||||||||
| 2025-06-30 | 450.57K shares 10-Q · filed 2026-08-13 | |||||||||
| 2025-03-31 | 10.71M shares 10-Q · filed 2026-05-14 | 450.57K shares 10-Q · filed 2025-05-13 | ||||||||
| 2024-12-31 | 320.55K shares 10-K · filed 2026-03-30 | 4.17M shares 10-K · filed 2025-03-27 | ||||||||
| 2024-09-30 | 319.83K shares 10-Q · filed 2025-11-05 | 4.16M shares 10-Q · filed 2024-11-12 | ||||||||
| 2024-06-30 | 309.10K shares 10-Q · filed 2025-08-11 | 4.02M shares 10-Q · filed 2024-08-08 | ||||||||
| 2024-03-31 | 450.57K shares 10-Q · filed 2026-05-14 | 3.94M shares 10-Q · filed 2024-05-09 | ||||||||
| 2023-12-31 | 3.69M shares 10-K · filed 2025-03-27 | |||||||||
| 2023-09-30 | 2.31M shares 10-Q · filed 2024-11-12 | |||||||||
| 2023-06-30 | 2.19M shares 10-Q · filed 2024-08-08 | |||||||||
| 2023-03-31 | 2.15M shares 10-Q · filed 2024-05-09 | |||||||||
| 2022-12-31 | 1.56M shares 10-K · filed 2024-03-19 | |||||||||
| 2022-09-30 | 1.64M shares 10-Q · filed 2023-11-08 | |||||||||
| 2022-06-30 | 1.66M shares 10-Q · filed 2023-08-10 | |||||||||
| 2022-03-31 | 1.08M shares 10-Q · filed 2023-05-10 | |||||||||
| 2021-12-31 | 796.67K shares 10-K · filed 2023-03-22 | |||||||||
| 2021-09-30 | 742.13K shares 10-Q · filed 2022-11-08 | |||||||||
| 2021-06-30 | 802.61K shares 10-Q · filed 2022-08-15 | |||||||||
| 2021-03-31 | 4.22M shares 10-Q · filed 2022-05-13 | 3.59M shares 10-Q · filed 2021-05-13 | ||||||||
| 2020-12-31 | 4.17M shares 10-K · filed 2022-03-29 | 3.81M shares 10-K · filed 2021-03-29 | ||||||||
| 2020-09-30 | 4.08M shares 10-Q · filed 2021-11-10 | 3.82M shares 10-Q · filed 2020-11-09 | ||||||||
| 2020-06-30 | 4.08M shares 10-Q · filed 2021-08-12 | 3.98M shares 10-Q · filed 2020-08-10 | ||||||||
| 2020-03-31 | 3.42M shares 10-Q · filed 2021-05-13 | |||||||||
| 2019-12-31 | 2.61M shares 10-K · filed 2021-03-29 | |||||||||
| 2019-09-30 | 2.73M shares 10-Q · filed 2020-11-09 | |||||||||
| 2019-06-30 | 2.81M shares 10-Q · filed 2020-08-10 | |||||||||
| 2019-03-31 | 2.56M shares 10-Q · filed 2020-05-08 | |||||||||
| 2018-12-31 | 1.94M shares 10-K · filed 2020-03-11 | |||||||||
| 2018-09-30 | 8.20M shares 10-Q · filed 2019-11-13 | |||||||||
| 2018-06-30 | 7.59M shares 10-Q · filed 2019-08-12 | |||||||||
| 2018-03-31 | 7.63M shares 10-Q · filed 2019-05-15 | |||||||||
| 2017-12-31 | 7.64M shares 10-K · filed 2019-04-01 | |||||||||
| 2016-12-31 | 4.66M shares 10-K · filed 2017-03-02 | |||||||||
| 2016-09-30 | 5.76M shares 10-Q · filed 2016-11-03 | |||||||||
| 2016-06-30 | 5.60M shares 10-Q · filed 2016-08-04 | |||||||||
| 2016-03-31 | 5.65M shares 10-Q · filed 2016-05-05 | |||||||||
| 2015-12-31 | 4.75M shares 10-K · filed 2017-03-02 | |||||||||
| 2015-09-30 | 4.76M shares 10-Q · filed 2016-11-03 | |||||||||
| 2015-06-30 | 4.86M shares 10-Q · filed 2016-08-04 | |||||||||
| 2015-03-31 | 4.11M shares 10-Q · filed 2016-05-05 | |||||||||
| 2014-12-31 | 4.01M shares 10-K · filed 2017-03-02 | |||||||||
| 2014-09-30 | 3.46M shares 10-Q · filed 2015-11-05 | |||||||||
| 2014-06-30 | 3.57M shares 10-Q · filed 2015-08-10 | |||||||||
| 2014-03-31 | 3.05M shares 10-Q · filed 2015-05-11 | 3.05M shares 10-Q · filed 2014-05-08 | ||||||||
| 2013-12-31 | 3.50M shares 10-K · filed 2016-02-26 | 3.50M shares 10-K · filed 2014-02-27 | ||||||||
| 2013-09-30 | 3.59M shares 10-Q · filed 2014-11-10 | |||||||||
| 2013-06-30 | 3.49M shares 10-Q · filed 2014-08-07 | |||||||||
| 2013-03-31 | 4.31M shares 10-Q · filed 2014-05-08 | |||||||||
| 2012-12-31 | 3.06M shares 10-K · filed 2015-03-16 | |||||||||
| 2011-12-31 | 6.00M shares 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |